New soluble-formazan assay for HIV-1 cytopathic effects: Application to high-flux screening of synthetic and natural products for AIDS-antiviral activity

Journal of the National Cancer Institute

Volumn 81, Issue 8, 1989, Pages 577-586

  Weislow, Owen S ^a   Kiser, Rebecca ^a   Fine, Donald L ^a   Bader, John ^b   Shoemaker, Robert H ^b   Boyd, Michael R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ASSAY; CELL CULTURE; DRUG SCREENING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOBLASTOID CELL LINE; METHODOLOGY; PRIORITY JOURNAL; TETRAZOLIUM DERIVATIVE;

ANTIVIRAL AGENTS; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; DRUG EVALUATION, PRECLINICAL; FORMAZANS; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV-1; HUMAN; INDICATORS AND REAGENTS; RETROVIRIDAE PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.; TETRAZOLIUM SALTS;

EID: 0024578841     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/81.8.577     Document Type: Article

References (23)

1. Mitsuya H, Weinhold DJ, Furman PA, et al: 3’-Azido-3’-dcoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type n/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 82:7096-7100, 1985
2. Mitsuya H, Matsukura M, Broder S: Rapid in vitro systems for assessing activity of agents against HTLV-III/LAV. In AIDS: Modern Concepts and Therapeutic Challenges (Broder S, ed). New York: Marcel Dekker, 1987, pp 303-333
3. Di Marzo Veronese F, Sarngadharan MG, Rahman R, et al: Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type ID. Proc Natl Acad Sci USA 82:5199-5202, 1985
4. Nara PL, Gerard RW, Matthew GA, et al: Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gpl20. Proc Natl Acad Sci USA 84:3797, 1987
5. Popovic M, Sarngadharan MG, Read E, et al: Detection, isolation, and continuous production of cytopathic retroviruses (HTVL-III) from patients with AIDS and pre-AIDS. Science 224:497-500, 1984
6. Harada S, Koyanagi Y, Yamamoto N: Infection of HTLV-III/LAV in HTLV-I carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229:563-566, 1985
7. Mitsuya H, Popovic M, Yarchoan R, et al: Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III. Science 226:172-174, 1984
8. Karpas A, Gillson W, Bevan PC, et al: Lytic infection by British AIDS virus and development of rapid cell test for antiviral antibodies. Lancet 2:695-697, 1985
9. Dalgleish AG, Beverley PCL, Clapham PR, et al: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-767, 1984
10. Nara PL, Hatch WC, Dunlop NM, et al.: Simple, rapid, quantitative, syncytium forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retroviruses 3:283-302, 1987
11. Boyd MR: Strategies for the identification of new agents for the treatment of AIDS: A national program to facilitate the discovery and preclinical development of new drug candidates for clinical evaluation. In AIDS Etiology Diagnosis, Treatment and Prevention, 1988 (DeVita VT Jr, Hellman S, Rosenberg SA, eds). Philadelphia: Lippincott, 1988, pp 305-317
12. Herrmann EC, Gabuks J Jr, Engle C, et al: Agar diffusion method for detection and bioassay of antiviral antibiotics. Proc Soc Exp Biol Med 103:625-628, 1960
13. Humbert JR, Marks ML Haathaway WE, et al: The histochemical nitroblue tetrazolium reduction test in differential diagnosis of acute infections. Pediatrics 48:259-267, 1971
14. Mosmann T: Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
15. Scuderio DA, Shoemaker RH, Alley MC, et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827-4833, 1988
16. Paull KD, Shoemaker RH, Boyd MR, et al: The synthesis of XTT—a new tetrazolium reagent that is bioreducible to a water-soluble formazan. J Heterocyclic Chem 25:511-914, 1988
17. 3 with HTLV-III/LAV is highly permissive and lytic. Virology 155:726-731, 1986
18. Williams GJ, Colby CB: Combined effects of R interferon beta and AZT on HIV replication in vitro. Antiviral Res 9:138, 1988
19. Ito M, Baba M, Sato A, et al: Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antiviral Res 7:361-367, 1987
20. Baba M, Pauwels R, Balzarini J, et au Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci USA 85:6132-6136, 1988
21. Montefiore DC, Robinson WE, Schuffman SS, et al: Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay. J Clin Microbiol 26:231-235, 1988
22. Pauwels R, Balzarini J, Baba M, et al.: Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HTV compounds. J Virol Methods 20:309-321, 1988
23. Vince R, Hua M, Brownell J, et al: Potent and selective activity of a new carbocyclic nucleoside analog (carbovin NSC 614846) against human immunodeficiency virus in vitro. Biochem Biophys Res Commun 156:1046-1053, 1988